A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE 2 STUDY OF THE ERC-1671 (GLIOVAC) VACCINE IN COMBINATION WITH BEVACIZUMAB (BEV) IN RECURRENT GBM PATIENTS: SAFETY LEAD-IN ANALYSIS

被引：0
|
作者：
Bota, Daniela [1 ]
Carrillo, Jose [1 ]
Kong, Xiao-Tang [1 ]
Fu, Dan [1 ]
Chung, Jinah [2 ]
Pretto, Chrystel [3 ]
Strik, Ankie [3 ]
Schijns, Virgil [3 ]
Stathopoulos, Apostolos [3 ]
机构：
[1] UC Irvine Med Ctr, Orange, CA USA
[2] UC Irvine Med Ctr, Irvine, CA USA
[3] ERC Belgium, Isnes, Belgium
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ATIM-20
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: VACCINE OVERALL SURVIVAL IN BEVACIZUMAB NAIVE AND BEVACIZUMAB RESISTANT PATIENTS
    Bota, Daniela
    Taylor, Thomas
    Kong, Xiao-Tang
    Fu, Beverly
    Hsu, Frank
    Strik, Ankie
    Schijns, Virgil
    Stathopoulos, Apostolos
    NEURO-ONCOLOGY, 2020, 22 : 34 - 34
  • [2] A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer
    van Die, M. Diana
    Williams, Scott G.
    Emery, Jon
    Bone, Kerry M.
    Taylor, Jeremy M. G.
    Lusk, Elizabeth
    Pirotta, Marie V.
    PROSTATE, 2017, 77 (07): : 765 - 775
  • [3] NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma
    Lee, Eudocia Q.
    Zhang, Peixin
    Wen, Patrick Y.
    Gerstner, Elizabeth R.
    Reardon, David A.
    Aldape, Kenneth D.
    deGroot, John F.
    Pan, Edward
    Raizer, Jeffrey J.
    Kim, Lyndon J.
    Chmura, Steven J.
    Robins, H. Ian
    Connelly, Jennifer M.
    Battiste, James D.
    Villano, John L.
    Wagle, Naveed
    Merrell, Ryan T.
    Wendland, Merideth M.
    Mehta, Minesh P.
    CANCER, 2020, 126 (12) : 2821 - 2828
  • [4] Efficacy and safety of YOXINTINE for depression: A double-blinded, randomized, placebo-controlled, phase 2 clinical trial
    Dong, Zaiquan
    Shen, Qi
    Zhu, Hanwen
    Yang, Zirong
    Lv, Jianqin
    Feng, Ruizhi
    Bai, Xue
    Huang, Guoping
    Hu, Yueqiang
    Pan, Liya
    Zhao, Guijun
    Jia, William
    Wang, Xue
    PHYTOMEDICINE, 2025, 136
  • [5] A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2 STUDY OF SAFETY, TOLERABILITY, AND EFFICACY OF PIRFENIDONE IN PATIENTS WITH RHEUMATOID ARTHRITIS INTERSTITIAL LUNG DISEASE
    Solomon, J.
    WOODHEAD, F.
    DANOFF, S.
    HAYNES-HARP, S.
    NAIK, T.
    SPINO, C.
    HURWITZ, S.
    MAURER, R.
    CHAMBERS, D.
    KOLB, M.
    GOLDBERG, H.
    ROSAS, I.
    CHEST, 2022, 161 (06) : 262A - 262A
  • [6] A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
    Solomon, Joshua
    Woodhead, Felix
    Danoff, Sonye
    Haynes-Harp, Shana
    Naik, Tanvi
    Spino, Cathie
    Hurwitz, Shelley
    Maurer, Rie
    Chambers, Daniel
    Kolb, Martin
    Goldberg, Hiliary
    Rosas, Ivan
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4105 - 4108
  • [7] Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Meeuwis, K.
    Sullivan, J.
    Cather, J. C.
    Yosipovitch, G.
    Gottlieb, A. B.
    Merola, J. F.
    Duffin, K. Callis
    Fretzin, S.
    Osuntokun, O. O.
    Burge, R.
    Naegeli, A. N.
    Yang, F. E.
    Lin, C. -Y.
    Todd, K.
    Bleakman, A. Potts
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 844 - 852
  • [8] Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study
    Youn, Sang Woong
    Jo, Seong Jin
    Park, Chul Jong
    Kim, Dong Hyun
    Shin, Bong Seok
    Jeong, Ki Heon
    Bang, Chul Hwan
    Cross, Nancy
    Thirlwell, Jackie
    Hoepken, Bengt
    JOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1392 - 1403
  • [9] A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases
    Weisman, Michael H.
    Paulus, Harold E.
    Burch, Francis X.
    Kivitz, Alan J.
    Fierer, Joshua
    Dunn, Meleana
    Kerr, David R.
    Tsuji, Wayne
    Baumgartner, Scott W.
    RHEUMATOLOGY, 2007, 46 (07) : 1122 - 1125
  • [10] DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: OS CORRELATIONS WITH INITIAL AND MAXIMUM CD4+T LYMPHOCYTE COUNT IN THE PERIPHERAL BLOOD
    Bota, Daniela
    Taylor, Thomas
    Kong Xiao-Tang
    Fu, Beverly
    Alsharif, Mohamad
    Pretto, Chrystel
    Strik, Ankie
    Schijns, Virgil
    Stathopoulos, Apostolos
    NEURO-ONCOLOGY, 2019, 21 : 10 - 11
12345